Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Clinical trial NCT03339128 · RECRUITING
Trial details
- NCT number
- NCT03339128
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2026-12-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.